Nicholas Spittal

Executive Vice President, Clinical Development

Nick has worked in ophthalmology since 2001 in a variety of project management, clinical development and business operations roles for small and large service organizations. He and his teams have been responsible for programs leading to approvals of a number of ophthalmic drugs, devices and diagnostics across retinal indications, glaucoma, dry eye, and orphan diseases. Nick is a member of Syneos Health’s Rare Disease and Biosimilar consortiums, and regularly consults with customers on regulatory strategy, study execution, and market positioning for eye care products.

Powered by GlobalLink OneLink Software